This research proposes that K2's superior adverse result event is owing, a minimum of partly, to unique JWH-018 metabolite action at the cannabinoid 1 receptor (CB1R), and suggests that metabolites of most drugs, but not the carboxy metabolite, retain in vitro As well as in vivo action at CB1Rs. Some https://eam220108541.total-blog.com/eam2201-no-further-a-mystery-56457906